373 related articles for article (PubMed ID: 22781470)
1. Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors.
Maioli M; Zeymer U; van 't Hof AW; Gibson CM; Dudek D; Bellandi F; Noc M; Secco GG; Zorman S; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Huber K; De Luca G;
J Invasive Cardiol; 2012 Jul; 24(7):324-7. PubMed ID: 22781470
[TBL] [Abstract][Full Text] [Related]
2. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.
De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F;
J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096
[TBL] [Abstract][Full Text] [Related]
3. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors.
De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Secco GG; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D
Heart Vessels; 2014 Jan; 29(1):15-20. PubMed ID: 23494604
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW
Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981
[TBL] [Abstract][Full Text] [Related]
5. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.
De Luca G; Gibson CM; Huber K; Dudek D; Cutlip D; Zeymer U; Gyöngyösi M; Bellandi F; Noc M; Arntz HR; Maioli M; Secco GG; Zorman S; Gabriel HM; Emre A; Rakowski T; Van't Hof AW;
EuroIntervention; 2012 Aug; 8(4):470-6. PubMed ID: 22917731
[TBL] [Abstract][Full Text] [Related]
6. Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).
De Luca G; Van't Hof AW; Gibson CM; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel HM; Emre A; Rakowski T; Gyongyosi M; Huber K; Bellandi F; Dudek D;
Am J Cardiol; 2015 Mar; 115(6):711-5. PubMed ID: 25655867
[TBL] [Abstract][Full Text] [Related]
7. Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.
De Luca G; Gibson CM; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Arntz HR; Dudek D; Rakowski T; Gyongyosi M; Huber K; van't Hof AW
J Thromb Thrombolysis; 2010 Jul; 30(1):23-8. PubMed ID: 19921103
[TBL] [Abstract][Full Text] [Related]
8. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.
De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW;
Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865
[TBL] [Abstract][Full Text] [Related]
9. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.
De Luca G; Gibson CM; Gyöngyösi M; Zeymer U; Dudek D; Arntz HR; Bellandi F; Maioli M; Noc M; Zorman S; Gabriel HM; Emre A; Cutlip D; Rakowski T; Huber K; van't Hof AW
J Thromb Thrombolysis; 2010 Oct; 30(3):342-6. PubMed ID: 20213259
[TBL] [Abstract][Full Text] [Related]
11. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty.
Uyarel H; Uzunlar B; Unal Dayi S; Tartan Z; Samur H; Kasikcioglu H; Akgul O; Simsek D; Erdem I; Okmen E; Cam N
Cardiology; 2006; 105(3):168-75. PubMed ID: 16479104
[TBL] [Abstract][Full Text] [Related]
12. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients.
Lavi S; Gruberg L; Kapeliovich M; Hammerman H; Boulos M; Grenadier E; Aronson D; Markiewicz W; Beyar R
J Invasive Cardiol; 2005 Jun; 17(6):296-9. PubMed ID: 16003002
[TBL] [Abstract][Full Text] [Related]
13. Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).
Tricoci P; Peterson ED; Chen AY; Newby LK; Harrington RA; Greenbaum AB; Cannon CP; Gibson CM; Hoekstra JW; Pollack CV; Ohman EM; Gibler WB; Roe MT
Am J Cardiol; 2007 May; 99(10):1389-93. PubMed ID: 17493466
[TBL] [Abstract][Full Text] [Related]
14. Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time.
Aquilina M; Varani E; Balducelli M; Vecchi G; Frassineti V; Maresta A
J Invasive Cardiol; 2009 Mar; 21(3):115-20. PubMed ID: 19258642
[TBL] [Abstract][Full Text] [Related]
15. A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
Gurm HS; Tamhane U; Meier P; Grossman PM; Chetcuti S; Bates ER
Circ Cardiovasc Interv; 2009 Jun; 2(3):230-6. PubMed ID: 20031720
[TBL] [Abstract][Full Text] [Related]
16. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Marino P
Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
[TBL] [Abstract][Full Text] [Related]
17. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
[TBL] [Abstract][Full Text] [Related]
18. Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty.
De Luca G; van't Hof AW; Huber K; Gibson CM; Bellandi F; Arntz HR; Maioli M; Noc M; Zorman S; Zeymer U; Gabriel HM; Emre A; Cutlip D; Rakowski T; Gyongyosi M; Dudek D;
Am J Cardiol; 2013 Oct; 112(8):1083-6. PubMed ID: 23910428
[TBL] [Abstract][Full Text] [Related]
19. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study.
Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S
Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719
[TBL] [Abstract][Full Text] [Related]
20. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials.
De Luca G; Navarese E; Marino P
Eur Heart J; 2009 Nov; 30(22):2705-13. PubMed ID: 19875386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
